{"id":15043,"date":"2022-06-23T08:55:20","date_gmt":"2022-06-23T07:55:20","guid":{"rendered":"https:\/\/actubusinessangels.com\/?p=15043"},"modified":"2022-06-23T08:55:20","modified_gmt":"2022-06-23T07:55:20","slug":"co-investissement-pour-le-financement-xprochem","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/co-investissement-pour-le-financement-xprochem\/","title":{"rendered":"Co-investissement pour le financement X&#8217;PROCHEM"},"content":{"rendered":"\n<p class=\"has-text-align-justify\">La soci\u00e9t\u00e9 lilloise de biotechnologie <strong><a href=\"http:\/\/X'PROCHEM,\" target=\"_blank\" rel=\"noreferrer noopener\">X&#8217;PROCHEM,<\/a><\/strong> sp\u00e9cialis\u00e9e dans la production de prot\u00e9ines th\u00e9rapeutiques, l\u00e8ve 1,8 millions d&#8217;euros pour investir dans un nouveau laboratoire de production r\u00e9glement\u00e9 BPF. Cette lev\u00e9e marque l\u2019entr\u00e9e \u00e0 son capital du groupe CliniSciences, et le r\u00e9investissement d&#8217;<strong><a href=\"https:\/\/www.angelssante.fr\/\">Angel Sant\u00e9<\/a><\/strong>, <strong><a href=\"https:\/\/www.am-businessangels.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Arts et M\u00e9tiers Business Angels<\/a><\/strong>, d&#8217;Ariane CapDev, du groupe IRD (Nord Cr\u00e9ation) ainsi que Nord France Amor\u00e7age, actionnaires historiques d\u2019X&#8217;PROCHEM. Cette op\u00e9ration vient en compl\u00e9ment de financements obtenus dans le cadre du plan France Relance.<\/p>\n\n\n\n<!--more-->\n\n\n\n<p class=\"has-text-align-justify\">Fond\u00e9e en 2012 \u00e0 l&#8217;Institut Pasteur de Lille, X&#8217;PROCHEM a d\u00e9velopp\u00e9 un process de production chimique de prot\u00e9ines personnalis\u00e9es. Cette technologie totalement robotis\u00e9e permet de concevoir et d\u00e9velopper des biom\u00e9dicaments jusqu&#8217;ici irr\u00e9alisables.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">Ces biom\u00e9dicaments sont un moteur essentiel de la croissance du secteur pharmaceutique, mais font face \u00e0 des challenges de tailles. <em>&#8220;La plupart d&#8217;entre eux sont produits par des syst\u00e8mes biologiques tr\u00e8s couteux \u00e0 mettre en \u0153uvre. Ces syst\u00e8mes font par ailleurs face \u00e0 des probl\u00e9matiques de puret\u00e9 et de reproductibilit\u00e9. Par notre approche chimique automatis\u00e9e, nous sommes capable de palier \u00e0 l&#8217;ensemble de ces probl\u00e8mes&#8221;<\/em>, explique Reda MHIDIA, CEO d&#8217;X&#8217;PROCHEM.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">Gr\u00e2ce \u00e0 cette lev\u00e9e de fonds, X&#8217;PROCHEM consolide sa position de partenaire de r\u00e9f\u00e9rence avec les soci\u00e9t\u00e9s pharmaceutiques pour le d\u00e9veloppement et la production de biom\u00e9dicaments.<\/p>\n\n\n\n<p class=\"has-text-align-justify\"><em>&#8220;Nous sommes tr\u00e8s fiers de pouvoir mettre en place cette nouvelle unit\u00e9 de production, qui va nous permettre d&#8217;accompagner nos clients dans le d\u00e9veloppement de leurs produits pharmaceutiques&#8221;<\/em>, annonce Julien DHEUR, CSO X&#8217;PROCHEM.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 lilloise de biotechnologie X&#8217;PROCHEM, sp\u00e9cialis\u00e9e dans la production de prot\u00e9ines th\u00e9rapeutiques, l\u00e8ve 1,8 millions d&#8217;euros pour investir dans un nouveau laboratoire de production r\u00e9glement\u00e9 BPF. Cette lev\u00e9e marque l\u2019entr\u00e9e \u00e0 son capital du groupe CliniSciences, et le r\u00e9investissement d&#8217;Angel Sant\u00e9, Arts et M\u00e9tiers Business Angels, d&#8217;Ariane CapDev, du groupe IRD (Nord Cr\u00e9ation) ainsi&hellip;<\/p>\n","protected":false},"author":114,"featured_media":15047,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[160,85],"tags":[147,761,75,397],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.7.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Co-investissement pour le financement X&#039;PROCHEM - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Co-investissement pour le financement X&#039;PROCHEM - France Angels\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 lilloise de biotechnologie X&#8217;PROCHEM, sp\u00e9cialis\u00e9e dans la production de prot\u00e9ines th\u00e9rapeutiques, l\u00e8ve 1,8 millions d&#8217;euros pour investir dans un nouveau laboratoire de production r\u00e9glement\u00e9 BPF. Cette lev\u00e9e marque l\u2019entr\u00e9e \u00e0 son capital du groupe CliniSciences, et le r\u00e9investissement d&#8217;Angel Sant\u00e9, Arts et M\u00e9tiers Business Angels, d&#8217;Ariane CapDev, du groupe IRD (Nord Cr\u00e9ation) ainsi&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-23T07:55:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/06\/xprochem-logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"425\" \/>\n\t<meta property=\"og:image:height\" content=\"227\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Co-investissement pour le financement X&#8217;PROCHEM\",\"datePublished\":\"2022-06-23T07:55:20+00:00\",\"dateModified\":\"2022-06-23T07:55:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/\"},\"wordCount\":276,\"commentCount\":580,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Angels Sant\u00e9\",\"Arts &amp; M\u00e9tiers Business Angels\",\"Lev\u00e9e de fonds\",\"X'ProChem\"],\"articleSection\":[\"2022\",\"Closing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/\",\"name\":\"Co-investissement pour le financement X'PROCHEM - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2022-06-23T07:55:20+00:00\",\"dateModified\":\"2022-06-23T07:55:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Co-investissement pour le financement X&#8217;PROCHEM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Co-investissement pour le financement X'PROCHEM - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/","og_locale":"en_US","og_type":"article","og_title":"Co-investissement pour le financement X'PROCHEM - France Angels","og_description":"La soci\u00e9t\u00e9 lilloise de biotechnologie X&#8217;PROCHEM, sp\u00e9cialis\u00e9e dans la production de prot\u00e9ines th\u00e9rapeutiques, l\u00e8ve 1,8 millions d&#8217;euros pour investir dans un nouveau laboratoire de production r\u00e9glement\u00e9 BPF. Cette lev\u00e9e marque l\u2019entr\u00e9e \u00e0 son capital du groupe CliniSciences, et le r\u00e9investissement d&#8217;Angel Sant\u00e9, Arts et M\u00e9tiers Business Angels, d&#8217;Ariane CapDev, du groupe IRD (Nord Cr\u00e9ation) ainsi&hellip;","og_url":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2022-06-23T07:55:20+00:00","og_image":[{"width":425,"height":227,"url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/06\/xprochem-logo.png","type":"image\/png"}],"author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Co-investissement pour le financement X&#8217;PROCHEM","datePublished":"2022-06-23T07:55:20+00:00","dateModified":"2022-06-23T07:55:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/"},"wordCount":276,"commentCount":580,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Angels Sant\u00e9","Arts &amp; M\u00e9tiers Business Angels","Lev\u00e9e de fonds","X'ProChem"],"articleSection":["2022","Closing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/","url":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/","name":"Co-investissement pour le financement X'PROCHEM - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2022-06-23T07:55:20+00:00","dateModified":"2022-06-23T07:55:20+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-le-financement-xprochem\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Co-investissement pour le financement X&#8217;PROCHEM"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/15043"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=15043"}],"version-history":[{"count":0,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/15043\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media\/15047"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=15043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=15043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=15043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}